121
TITLE: Foreword
AUTHORS: Vincent Soriano; Walid Heneine; Anne Mieke Vandamme; Genoveffa Franchini;
PUBLISHED: 2008, SOURCE: AIDS REVIEWS, VOLUME: 10, ISSUE: 1
INDEXED IN: Scopus WOS
122
TITLE: The epidemic history of hepatitis C among injecting drug users in Flanders, Belgium  Full Text
AUTHORS: Mathei, C; Van Dooren, S; Lemey, P; Van Damme, P; Buntinx, F; M Vandamme;
PUBLISHED: 2008, SOURCE: JOURNAL OF VIRAL HEPATITIS, VOLUME: 15, ISSUE: 6
INDEXED IN: Scopus WOS
123
TITLE: Impact on replicative fitness of the G48E substitution in the protease of HIV-1 - An in vitro and in silico evaluation
AUTHORS: Jean Marie Zimmer; Francois Roman; Christine Lambert; Abel Jonckheer; Ana Vazquez; Jean Marc Plesseria; Jean Yves Servais; Kris Covens; Jan Weber; Kristel Van Laethem; Jean Claude Schmit; Anne Mieke Vandamme; Miguel E Quinones Mateu; Marc De Maeyer;
PUBLISHED: 2008, SOURCE: JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, VOLUME: 48, ISSUE: 3
INDEXED IN: Scopus WOS
124
TITLE: Understanding the changing prevalence of K65R
AUTHORS: Kristof Theys; Anne Mieke Vandamme;
PUBLISHED: 2008, SOURCE: AIDS REVIEWS, VOLUME: 10, ISSUE: 2
INDEXED IN: Scopus WOS
125
TITLE: Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards  Full Text
AUTHORS: Ann E Deschamps; Sabina De Geest; Anne Mieke Vandamme; Herman Bobbaers; Willy E Peetermans; Eric Van Wijngaerden;
PUBLISHED: 2008, SOURCE: AIDS PATIENT CARE AND STDS, VOLUME: 22, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef
126
TITLE: A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes  Full Text
AUTHORS: Kristel Van Laethem; Yoeri Schrooten; Kris Covens; Nathalie Dekeersmaeker; Paul De Munter; Eric Van Wijngaerden; Marc Van Ranst; Anne Mieke Vandamme;
PUBLISHED: 2008, SOURCE: JOURNAL OF VIROLOGICAL METHODS, VOLUME: 153, ISSUE: 2
INDEXED IN: Scopus WOS CrossRef
127
TITLE: Multi-Science Decision Support for HIV Drug Resistance Treatment
AUTHORS: Peter Sloot; Peter Coveney; Marian T Bubak; Anne Mieke Vandamme; Breanndan O Nuallain; David van de Vijver; Charles Boucher;
PUBLISHED: 2008, SOURCE: 6th HealthGrid Conference in GLOBAL HEALTHGRID: E-SCIENCE MEETS BIOMEDICAL INFORMATICS, VOLUME: 138
INDEXED IN: Scopus WOS
128
TITLE: Proof-of-principle evaluation of predictive performance for therapy outcome of baseline estimated fitness and genetic barrier towards resistance in a clinical cohort of HIV-1-treated patients
AUTHORS: Deforche, K; Cozzi Lepri, A; Theys, K; Clotet, B; Camacho, R; Kjaer, J; Van Laethem, K; Phillips, AN; Moreau, Y; Lundgren, JD; Vandamme, AM;
PUBLISHED: 2007, SOURCE: 16th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 12
INDEXED IN: WOS
129
TITLE: Mutations in HIV-2 protease selected by protease-inhibitor therapy
AUTHORS: Cavaco C Silva; Cabanas, J; Goncalves, MF; Van Laethem, K; Vandamme, AM; Gomes, P; Camacho, RJ;
PUBLISHED: 2007, SOURCE: 16th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 12
INDEXED IN: WOS
130
TITLE: Mutations in HIV-2 protease selected by proteaseinhibitor therapy
AUTHORS: Cavaco C Silva; Cabanas, J; Goncalves, MF; Van Laethem, K; Vandamme, AM; Gomes, P; Camacho, RJ;
PUBLISHED: 2007, SOURCE: 16th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 12, ISSUE: 5
INDEXED IN: WOS
Page 13 of 42. Total results: 417.